Bienville Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,824
Closed -$210K 149
2020
Q2
$210K Buy
+2,824
New +$213K 0.02% 130
2018
Q1
Sell
-6,048
Closed -$328K 182
2017
Q4
$328K Sell
6,048
-1,230
-17% -$68.2K 0.06% 134
2017
Q3
$447K Sell
7,278
-2,770
-28% -$168K 0.08% 90
2017
Q2
$619K Buy
10,048
+3,144
+46% +$191K 0.17% 58
2017
Q1
$422K Buy
6,904
+453
+7% +$27.5K 0.1% 80
2016
Q4
$365K Sell
6,451
-105
-2% -$6.14K 0.08% 86
2016
Q3
$392K Sell
6,556
-304
-4% -$17.8K 0.1% 80
2016
Q2
$378K Buy
+6,860
New +$365K 0.1% 72
2015
Q1
Sell
-10,480
Closed -$568K 80
2014
Q4
$568K Buy
+10,480
New +$584K 0.47% 34

Other funds holding MRK

Bienville Capital Management's MRK Position: Q3 2020 in Review

Bienville Capital Management sold out of Merck (MRK) in Q3 2020, closing a stake of 2,824 shares — an estimated $210K sold.

Bienville Capital Management first reported a position in MRK in Q4 2014 and held it in 9 quarters. The position peaked at $619K in Q2 2017. 2,558 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

  • Bienville Capital Management reported no remaining Merck position as of Q3 2020 after selling out during the quarter.
  • Bienville Capital Management sold 2,824 Merck shares in Q3 2020, an estimated $210K.
  • Bienville Capital Management first reported a position in Merck in Q4 2014 and held it in 9 quarters.
  • Bienville Capital Management's Merck position peaked at $619K in Q2 2017.
  • 2,558 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Bienville Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.